OLIVIA WILLIAMSON: Open Payments
NPI 1477338184 · SEBEWAING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,058 in 103 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $844 · 2025 $2,058
Food & beverage: $1,774Education: $284
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $469 |
| ABBVIE INC. | 28 | $335 |
| UCB, Inc. | 11 | $235 |
| GENZYME CORPORATION | 9 | $198 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $190 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Incyte Corporation | 3 | $55 |
| Amgen Inc. | 3 | $54 |
Products named: TREMFYA, DUPIXENT, Bimzelx, RINVOQ, SKYRIZI, SPEVIGO, OPZELURA, OTEZLA.
Industry payments across MI — which companies pay providers there.
